Stem Cell Therapy Market: Top 5 trends fueling the industry revenue through 2025

The global stem therapy market growth will be driven by extensive R&D activities aimed at developing novel therapies and personalized medicines. For example, to treat patients who have suffered a myocardial infarction (heart attack), scientists are emphasizing on developing techniques to regenerate healthy heart from placental stem cells.

As per the Centers for Disease Control and Prevention (CDC), heart diseases in the U.S. cause nearly 655,000 deaths each year. The development of novel therapies will aid in treating patients suffering from cardiovascular disease more effectively and reducing mortality rates. Ongoing examination of the different aspects of stem cell therapy by researchers to explore its application in neurological disorders can help in the treatment of complex diseases.

According to a Global Market Insights, Inc., report, stem cell therapy market size will surpass US$15 billion by 2025.

Described below are some key factors driving the stem cell therapy market trends.

Higher risk of degenerative diseases among the elderly

The substantial rise in the geriatric population and increasing chronic ailments would boost the demand for stem cell therapies. Older people happen to be more vulnerable to degenerative diseases such as Alzheimer’s and Parkinson’s disorders. As compared to traditional therapeutic methods, the various benefits of stem cell therapy can make it preferable for the treatment of degenerative diseases. Newer solutions are based on minimally invasive techniques that generate healthy cells by replacing the defectives cells in the host.

Use of allogenic stem cell therapy in leukemia treatment

Allogenic transplant is used to completely replace host cells with the donor cells. It also possesses the potential to eliminate viral reservoirs and genetic alterations in host cells. Because of these capabilities, allogenic stem cell therapy is used for treating patients suffering from leukemia and other chronic disorders.

Reportedly, the annual valuation of allogenic stem cell therapy market was estimated to be worth US$3 billion in 2018 and it will grow substantially in the forthcoming years.

To access sample pages of this report titled, “Stem Cell Therapy Market Size By Type (Allogenic Stem Cell Therapy, Autologous Stem Cell Therapy), By Application (Oncology, Orthopedic, Cardiovascular, Neurology), End-users (Hospitals, Clinics) Industry Analysis Report, Regional Outlook, Technology Potential, Competitive Market Share & Forecast, 2019 - 2025” in detail along with the table of contents, please click on the link below:

https://www.gminsights.com/request-sample/detail/3331

Global increase in trauma cases and bone-joint injuries

Rising incidences of accidents and trauma cases across the globe will augment demand for orthopedic care solutions. Stem cell therapy has a high success rate in the treatment of bone-joint injuries such as ligament tendon, osteogenesis imperfecta, femoral head, spinal, and fractured bone defects.

Additionally, the growing preference for mesenchymal stem cell therapy in nursing orthopedic diseases such as osteoporosis and arthritis can be attributed to its ability differentiate bones and cartilage Notably, the share of orthopedic application segment of stem cell therapy is estimated to rise at a significant CAGR of 9% up to 2025.

Availability of advanced stem cell therapies in clinical settings

The availability of technologically advanced medical equipment and highly skilled professionals in clinical facilities enable the delivery of safe and superior quality stem cell therapies. Clinics can provide specialized stem cell treatment for a wide range of applications including orthopedics, oncology, and cardiovascular disorders. Reportedly, clinics accounted for more than 35% revenue share of stem cell therapy market in 2018.

Increasing burden of chronic diseases in Europe

Europe’s stem cell therapy market is projected to experience a CAGR of nearly 10% up to 2025. The escalating prevalence of various chronic diseases will drive the demand for advanced therapeutic solutions in the region. Ongoing efforts from regulatory bodies to create awareness regarding stem cell therapy and its advantages among people will bolster the regional industry outlook.

The presence of stringent regulations pertaining to the quality control of these therapies could affect its adoption rate slightly. However, their high success rate in the treatment of complex diseases will fuel global stem cell therapy market expansion in near future.

Prominent firms involved in the development of novel stem cell therapy solutions include Takeda Pharmaceuticals, ReNeuron Group, Celyad, Capricor Therapeutics, Gamida Cell, Novadip Biosciences, Cellular Dynamics, DiscGenics, CESCA Therapeutics, Mesoblast, OxStem, Cellectis, and Astellas Pharma. These companies are focusing on several strategies such as acquisitions, mergers, and new product development to sustain their market position.

About Global Market Insights, Inc.

Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider, offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy, and biotechnology.

Contact Us:

Arun Hegde
Corporate Sales, USA
Global Market Insights, Inc.
Phone: 1-302-846-7766
Toll Free: 1-888-689-0688
Email: sales@gminsights.com
Website: https://www.gminsights.com

Back to news